{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:36:37Z","timestamp":1784774197319,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1067\/mhj.2002.119766","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"277-282","source":"Crossref","is-referenced-by-count":20,"title":["Fibrinogen: Associations with cardiovascular events in an outpatient clinic"],"prefix":"10.1067","volume":"143","author":[{"given":"Monica","family":"Acevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnne Micale","family":"Foody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.119766_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(57)90768-7","article-title":"Coagulability of the blood in ischaemic heart disease","volume":"2","author":"McDonald","year":"1957","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.119766_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(80)91498-1","article-title":"Haemostatic function and cardiovascular death: early results of a prospective study","volume":"1","author":"Meade","year":"1980","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.119766_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/hrt.47.5.490","article-title":"Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study","volume":"47","author":"Baker","year":"1982","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2002.119766_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.119766_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/hrt.53.5.483","article-title":"Haemostatic factors and ischaemic heart disease. The Caerphilly study","volume":"53","author":"Yarnell","year":"1985","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2002.119766_bib6","first-page":"33","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.119766_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease. The Framingham Study","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1067\/mhj.2002.119766_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.83.3.836","article-title":"Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies","volume":"83","author":"Yarnell","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.119766_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.ATV.14.1.54","article-title":"Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men","volume":"14","author":"Heinrich","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1067\/mhj.2002.119766_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1365-2141.1997.1232935.x","article-title":"Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease","volume":"97","author":"Woodward","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1067\/mhj.2002.119766_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198405033101801","article-title":"Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death","volume":"310","author":"Davies","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.119766_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.119766_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"10.1067\/mhj.2002.119766_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/16.suppl_A.11","article-title":"Fibrinogen, fibrin and the arterial wall","volume":"16","author":"Smith","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.96.4.1102","article-title":"Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"96","author":"Folsom","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.119766_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/euhj.1997.0573","article-title":"Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study","volume":"19","author":"Woodward","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib17","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.19.7.1776","article-title":"The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2002.119766_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0021-9150(90)90108-U","article-title":"Fibrinogen, factor VII clotting activity and coronary artery disease severity","volume":"85","author":"Broadhurst","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1067\/mhj.2002.119766_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/14.1.8","article-title":"baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography","volume":"14","author":"ECAT angina pectoris study","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.119766_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archinte.1988.00380010040006","volume":"148","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1067\/mhj.2002.119766_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2141.1998.00604.x","article-title":"The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies","volume":"100","author":"Sweetnam","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1067\/mhj.2002.119766_bib23","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"Suppl A","key":"10.1067\/mhj.2002.119766_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/16.suppl_A.21","article-title":"Epidemiology of fibrinogen","volume":"16","author":"Folsom","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.ATV.19.6.1368","article-title":"Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update","volume":"19","author":"Maresca","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2002.119766_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2002.119766_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/hrt.69.4.338","article-title":"Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study","volume":"69","author":"Lee","year":"1993","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2002.119766_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1378\/chest.81.5.571","article-title":"Association of recurrent myocardial infarction with hemostatic factors: a prospective study","volume":"81","author":"Kostis","year":"1982","journal-title":"Chest"},{"key":"10.1067\/mhj.2002.119766_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.ATV.12.9.1063","article-title":"The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group","volume":"12","author":"Cortellaro","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1067\/mhj.2002.119766_bib30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","article-title":"Influence of platelet size on outcome after myocardial infarction","volume":"338","author":"Martin","year":"1991","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.119766_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oxfordjournals.eurheartj.a060141","article-title":"Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART)","volume":"13","author":"Burr","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.ATV.16.3.351","article-title":"Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group","volume":"16","author":"Benderly","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl A","key":"10.1067\/mhj.2002.119766_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/eurheartj\/16.suppl_A.47","article-title":"Therapeutic interventions to lower plasma fibrinogen concentration","volume":"16","author":"Ernst","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.119766_bib34","first-page":"155","article-title":"Fibrinogen and cardiovascular disorders","volume":"88","author":"Lip","year":"1995","journal-title":"QJM"},{"key":"10.1067\/mhj.2002.119766_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0038-1647146","article-title":"Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo","volume":"64","author":"Hampton","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.119766_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0049-3848(94)90177-5","article-title":"Short-term aspirin treatment does not reduce plasma fibrinogen concentration in young healthy adults","volume":"75","author":"Krusius","year":"1994","journal-title":"Thromb Res"},{"key":"10.1067\/mhj.2002.119766_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.ATV.16.2.262","article-title":"Plasma fibrinogen and coronary heart disease in elderly Japanese-American men","volume":"16","author":"Sharp","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2002.119766_bib38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.119766_bib39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.ATV.17.6.1121","article-title":"Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project","volume":"17","author":"Tracy","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2002.119766_bib40","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"96","author":"Toss","year":"1997","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302058519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302058519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:46:11Z","timestamp":1576460771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302058519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0002870302058519"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.119766","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}